J. Babich

J. Udelson, J. Babich, Christopher J Pastore, 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Synthesis and SAR of novel Re/99mTc-labeled benzenesulfonamide carbonic anhydrase IX inhibitors for molecular imaging of tumor hypoxia.

W. Eckelman, J. Babich, S. Hillier, 2013, Journal of medicinal chemistry.

Small molecule inhibitors of PSMA incorporating technetium-99m for imaging prostate cancer: Effects of chelate design on pharmacokinetics

W. Eckelman, J. Marquis, J. Babich, 2012 .

Dual-Target Binding Ligands with Modulated Pharmacokinetics for Endoradiotherapy of Prostate Cancer

James M. Kelly, D. S. Hage, J. Babich, 2017, The Journal of Nuclear Medicine.

Differential penetration of targeting agents into multicellular spheroids derived from human neuroblastoma.

J. Babich, R. Mairs, W. Angerson, 1991, Progress in clinical and biological research.

An improved tungsten-178/tantalum-178 generator system for high volume clinical applications.

M. Verani, J. Babich, R. Roberts, 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Evaluation of Melanin-Targeted Radiotherapy in Combination with Radiosensitizing Drugs for the Treatment of Melanoma

J. Babich, M. Boyd, R. Mairs, 2014, Cancer and Oncology Research.

Positron Emission Tomography: Clinical Applications and Pharmaceutical Care

J. Babich, R. Hammes, 1994 .

Evaluation of copper(II)-pyruvaldehyde bis (N-4-methylthiosemicarbazone) for tissue blood flow measurement usina a trapped tracer model

S. Cherry, R. Ott, J. Babich, 1994, European Journal of Nuclear Medicine.

A Phase 2 study of 99mTc-trofolastat (MIP-1404) to identify prostate cancer (PCa) in high-risk patients (pts) undergoing radical prostatectomy (RP) and extended pelvic lymph node (ePLN) dissection: an interim analysis

W. Ellis, K. Goffin, S. Joniau, 2014 .

Comparison of high-specific-activity ultratrace 123/131I-MIBG and carrier-added 123/131I-MIBG on efficacy, pharmacokinetics, and tissue distribution.

J. Babich, S. Hillier, K. Maresca, 2010, Cancer biotherapy & radiopharmaceuticals.

Radiation dosimetry, pharmacokinetics, and safety of ultratrace Iobenguane I-131 in patients with malignant pheochromocytoma/paraganglioma or metastatic carcinoid.

R. Coleman, M. de la Guardia, J. Babich, 2009, Cancer biotherapy & radiopharmaceuticals.

Liposomes and Micelles to Target the Blood Pool for Imaging Purposes

V. Torchilin, V. Weissig, J. Babich, 2000 .

Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease

S. Nehmeh, P. Mozley, H. Rusinek, 2021, Fluids and barriers of the CNS.

Decreased cerebral glucose utilization in rats during the ebb phase of thermal injury.

R. Tompkins, J. Correia, J. Babich, 1996, The Journal of trauma.

c-erbB2 protein overexpression in breast cancer as a target for PET using iodine-124-labeled monoclonal antibodies.

R. Ott, S. Eccles, J. Babich, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

JHU-2545 Selectively Shields Salivary Glands and Kidneys during PSMA-Targeted Radiotherapy

C. Kratochwil, Marie-France Penet, D. Abou, 2018, bioRxiv.

Experimental treatment of neuroblastoma using [131I]meta-iodobenzylguanidine and topotecan in combination.

S. Pimlott, M. Gaze, J. Babich, 2008, The British journal of radiology.

Synthesis and characterization of rhenium and technetium-99m labeled insulin.

J. Zubieta, J. Valliant, J. Babich, 2010, Journal of medicinal chemistry.

Quantitative study of radioiodinated metaiodobenzylguanidine uptake in children with neuroblastoma: correlation with tumor histopathology.

J. Babich, S. Meller, R. Carter, 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Detection of acute bacterial infection within soft tissue injuries using a 99mTc-labeled chemotactic peptide.

A. Fischman, R. Tompkins, R. Rubin, 1995, The Journal of trauma.

Comparison of the infection imaging properties of a 99mTc labeled chemotactic peptide with 111In IgG.

A. Fischman, J. Babich, W. Graham, 1995, Nuclear medicine and biology.

Imaging of focal sites of inflammation in rhesus monkeys with 99mTc-labeled human polyclonal IgG.

A. Fischman, R. Rubin, H. Strauss, 1994, Nuclear medicine and biology.

Localization of indium-111-immunoglobulin G, technetium-99m-immunoglobulin G and indium-111-labeled white blood cells at sites of acute bacterial infection in rabbits.

A. Fischman, R. Rubin, J. Babich, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Thiol- and thioether-based bifunctional chelates for the {M(CO)3}+ core (M = Tc, Re).

J. Zubieta, J. Valliant, P. Schaffer, 2005, Inorganic chemistry.

Synthesis and characterization of a ‘3+2’ {Re(V)O}3+ core complex carrying the ONS/PO donor atom set

J. Zubieta, J. Babich, F. Femia, 2001 .

Schiff base chemistry of the rhenium(V)-oxo core with '3+2' ligand donor sets.

J. Zubieta, J. Babich, F. Femia, 2001, Inorganica chimica acta.

The syntheses and structures of '3+2' and '2+2+1' oxorhenium mixed-ligand complexes employing 8-hydroxy-5-nitroquinoline as the bidentate N,O donor ligand.

J. Zubieta, J. Babich, F. Femia, 2000, Inorganica chimica acta.

Syntheses and structural characterization of rhenium-bis-hydrazinopyrimidine core complexes with thiolate and Schiff base coligands.

J. Zubieta, J. Babich, K. Maresca, 2000, Inorganica chimica acta.

Synthesis and crystal and molecular structure of a tetranuclear cluster based on the rhenium(III)-bisorganohydrazino core: [Re(HNNC(4)H(3)N(2))(NNC(4)H(3)N(2))(OCH(3))(2)](4).

J. Zubieta, J. Babich, K. Maresca, 2000, Inorganica chimica acta.

Metaiodobenzylguanidine: evaluation of its potential as a tracer for monitoring doxorubicin cardiomyopathy.

A. Fischman, H. Strauss, J. Babich, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Synthesis of [11C]palmitic acid for PET imaging using a single molecular sieve 13X cartridge for reagent trapping, radiolabeling and selective purification.

James M. Kelly, J. Babich, A. Amor-Coarasa, 2015, Nuclear medicine and biology.

An antibody-desferrioxamine conjugate labelled with 67Ga.

V. R. McCready, R. Ott, J. Babich, 1986, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

The effect of circulating antigen and radiolabel stability on the biodistribution of an indium labelled antibody.

W. Waddington, B. Davidson, J. Babich, 1991, British Journal of Cancer.

Phase I dose-escalation study of PSMA-targeted alpha emitter 225Ac-J591 in men with metastatic castration-resistant prostate cancer (mCRPC).

S. Vallabhajosula, N. Bander, C. Sternberg, 2020 .

Dose-escalation results of a phase I study of 225Ac-J591 for progressive metastatic castration resistant prostate cancer (mCRPC).

S. Vallabhajosula, N. Bander, C. Sternberg, 2020 .

Preliminary results of a phase I/II dose-escalation study of fractionated dose 177Lu-PSMA-617 for progressive metastatic castration resistant prostate cancer (mCRPC)

H. Beltran, S. Vallabhajosula, N. Bander, 2019, Annals of Oncology.

A Single Dose of 225Ac-RPS-074 Induces a Complete Tumor Response in an LNCaP Xenograft Model

James M. Kelly, Justin J. Wilson, D. Schlyer, 2018, The Journal of Nuclear Medicine.

Trifunctional PSMA-targeting constructs for prostate cancer with unprecedented localization to LNCaP tumors

James M. Kelly, D. Schlyer, Yize Zhao, 2018, European Journal of Nuclear Medicine and Molecular Imaging.

Treatment planning for 131I-mIBG radiotherapy of neural crest tumours using 124I-mIBG positron emission tomography.

D. Tait, R. Ott, M. Flower, 1992, The British journal of radiology.

An Eighteen-Membered Macrocyclic Ligand for Actinium-225 Targeted Alpha Therapy.

James M. Kelly, Justin J. Wilson, P. Schaffer, 2017, Angewandte Chemie.

New directions in the coordination chemistry of 99mTc: a reflection on technetium core structures and a strategy for new chelate design.

J. Zubieta, J. Valliant, S. Banerjee, 2005, Nuclear medicine and biology.

Bifunctional chelates with aliphatic amine donors for labeling of biomolecules with the {Tc(CO)3}+ and {Re(CO)3}+ cores: the crystal and molecular structure of [Re(CO)3{(H2NCH2CH2)2 N(CH2)4CO2Me}]Br ☆

J. Zubieta, S. Banerjee, J. Babich, 2004 .

6-Mercaptomethylpyridine-3-carboxylic acid (MEMNIC): a new reagent for peptide labeling with Tc-99m

A. Fischman, J. Zubieta, J. Babich, 2001 .

Myocardial substrate utilization and left ventricular function in adriamycin cardiomyopathy.

A. Fischman, H. Strauss, J. Babich, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18F]Fluoroethyltriazolyl Monocyclam Derivatives as Imaging Probes for the Chemokine Receptor CXCR4

James M. Kelly, M. Jin, J. Babich, 2019, Molecules.

Fluoroethyltriazolyl Monocyclam Derivatives as Imaging Probes for the Chemokine Receptor CXCR 4

James M. Kelly, M. Jin, J. Babich, 2019 .

Ongoing phase I evaluation of MTD, safety and efficacy of iobenguane I 131 in malignant pheochromocytoma and paraganglioma (Pheo)

R. Coleman, M. Morse, J. Babich, 2008 .

Technetium-99m-labeled hydrazino nicotinamide derivatized chemotactic peptide analogs for imaging focal sites of bacterial infection.

A. Fischman, R. Tompkins, R. Rubin, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

The high molecular weight of intact antibodies and even Fab fragments limits localization diffusion, which usually requires long intervals between administration and record

A. Fischman, H. Strauss, J. Babich, 2006 .

[131I]MIP-1466, a small molecule prostate-specific membrane antigen (PSMA) inhibitor for targeted radiotherapy of prostate cancer (PCa)

W. Eckelman, J. Marquis, J. Babich, 2012 .

Phase I Trial of 90Y-DOTATOC Therapy in Children and Young Adults with Refractory Solid Tumors That Express Somatostatin Receptors

Y. Menda, J. Babich, D. Bushnell, 2010, The Journal of Nuclear Medicine.

The distribution of alternative agents for targeted radiotherapy within human neuroblastoma spheroids.

M. Gaze, J. Babich, R. Mairs, 1991, British Journal of Cancer.

Technetium-99m-labeled chemotactic peptides: comparison with indium-111-labeled white blood cells for localizing acute bacterial infection in the rabbit.

A. Fischman, R. Tompkins, R. Rubin, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

In vivo bioactivity and biodistribution of chemotactic peptide analogs in nonhuman primates.

A. Fischman, R. Tompkins, R. Rubin, 1993, Journal of Nuclear Medicine.

on Efficacy, Pharmacokinetics, and Tissue Distribution

J. Babich, S. Hillier, K. Maresca, 2018 .

Preclinical evaluation of a high affinity sarcophagine-containing PSMA ligand for 64Cu/67Cu-based theranostics in prostate cancer.

James M. Kelly, D. Schlyer, J. Babich, 2020, Molecular pharmaceutics.

Measurement of muscle protein synthesis by positron emission tomography with L-[methyl-11C]methionine.

N. Alpert, A. Fischman, R. Tompkins, 1996, Proceedings of the National Academy of Sciences of the United States of America.

99mTc-HMPAO as a tumour blood flow agent

V. R. McCready, J. Babich, G. Coghlan, 2004, European Journal of Nuclear Medicine.

Quantitative in vivo measurements of tumor perfusion using rubidium-81 and positron emission tomography.

I. A. Watson, S. Cherry, J. Babich, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Synthesis and validation of fatty acid analogs radiolabeled by nonisotopic substitution

W. Eckelman, J. Babich, 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Radioiodinated Capsids Facilitate In Vivo Non-Invasive Tracking of Adeno-Associated Gene Transfer Vectors

H. Voss, S. Vallabhajosula, D. Ballon, 2017, Scientific Reports.

Effect of "co-ligand" on the biodistribution of 99mTc-labeled hydrazino nicotinic acid derivatized chemotactic peptides.

A. Fischman, J. Babich, Fischman Aj, 1995, Nuclear medicine and biology.

Design and synthesis of site directed maleimide bifunctional chelators for technetium and rhenium.

J. Zubieta, J. Valliant, S. Banerjee, 2005, Dalton transactions.

Initial experience with Tc-99m-HM-PAO in the study of brain tumors

V. R. McCready, R. Ott, M. Flower, 2004, European Journal of Nuclear Medicine.

Synthesis of [1-11C]Butanol via a facile solid phase extraction protocol.

M. D. de Leon, J. Babich, Wenchao Qu, 2020, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Impact of elution impurities on DOTA and NOTA labeling with two commercial 68Ge/68Ga generators

A. McGoron, J. Babich, S. Gulec, 2018, Journal of Radioanalytical and Nuclear Chemistry.

Continuation of comprehensive quality control of the itG 68Ge/68Ga generator and production of 68Ga-DOTATOC and 68Ga-PSMA-HBED-CC for clinical research studies.

James M. Kelly, S. Vallabhajosula, J. Babich, 2017, Nuclear medicine and biology.

Implications of the uptake of 131I-radiolabelled meta-iodobenzylguanidine (mIBG) for the targeted radiotherapy of neuroblastoma.

A. Barrett, T. Wheldon, J. Babich, 1991, The British journal of radiology.

Radiosensitization of noradrenaline transporter-expressing tumour cells by proteasome inhibitors and the role of reactive oxygen species

J. Babich, M. Boyd, R. Mairs, 2013, EJNMMI Research.

Bridging the gap between in vitro and in vivo imaging: isostructural Re and 99mTc complexes for correlating fluorescence and radioimaging studies.

J. Brennan, J. Zubieta, J. Lemon, 2004, Journal of the American Chemical Society.

18F-labeling and biodistribution of the novel fluoro-quinolone antimicrobial agent, trovafloxacin (CP 99,219).

A. Fischman, R. Rubin, J. Babich, 1996, Nuclear medicine and biology.

Synthesis and biodistribution of 18F-labeled fleroxacin.

N. Alpert, J. Correia, R. Rubin, 1993, Nuclear medicine and biology.

Single Amino Acid Chelates (SAAC): A Strategy for the Design of Technetium and Rhenium Radiopharmaceuticals

J. Zubieta, J. Valliant, J. Babich, 2009 .

New Directions in the Coordination Chemistry of 99mTc: A Reflection on Technetium Core Structures and a Strategy for New Chelate Design

J. Zubieta, J. Valliant, S. Banerjee, 2005 .

A convenient synthesis, chemical characterization and reactivity of [Re(CO)3(H2O)3]Br: the crystal and molecular structure of [Re(CO)3(CH3CN)2Br]

J. Zubieta, J. Babich, N. Lazarova, 2004 .

Triazole Appending Agent (TAAG): A New Synthon for Preparing Iodine-Based Molecular Imaging and Radiotherapy Agents.

J. Valliant, J. Babich, S. Hillier, 2012, ACS medicinal chemistry letters.

Procédé de production d'hétérodimères d'acide glutamique

J. Babich, K. Maresca, C. Zimmerman, 2010 .

Novel polar single amino acid chelates for technetium-99m tricarbonyl-based radiopharmaceuticals with enhanced renal clearance: application to octreotide.

W. Eckelman, J. Marquis, J. Babich, 2010, Bioconjugate chemistry.

Spectroscopic and structural studies of complexes of the fac-[Re(N∩N)(CO)3L]n+ type (N∩N=2-(2-pyridyl)benzothiazole; L=Cl, Br, CF3SO3 −, CH3CN)

J. Zubieta, J. Babich, F. Femia, 2001 .

Synthesis, characterization, and biodistribution of a Technetium-99m ‘3+1’ fatty acid derivative. The crystal and molecular structures of a series of oxorhenium model complexes

A. Fischman, J. Zubieta, T. Shoup, 2002 .

Preoperative imaging of colorectal cancers. Targeting the epithelial membrane antigen with a radiation‐labeled monoclonal antibody

W. Waddington, P. Ell, B. Davidson, 1992, Cancer.

Phase-1 Clinical Trial Results of High-Specific-Activity Carrier-Free 123I-Iobenguane

N. Petry, J. Babich, M. Stabin, 2014, The Journal of Nuclear Medicine.

Phase-1 Clinical Trial Results of High-Specific-Activity Carrier-Free 123 I-Iobenguane

N. Petry, J. Babich, M. Stabin, 2014 .

Synthesis and structural characterization of rhenium(I) tricarbonyl complexes with the bidentate ligands o-(diphenylphosphino)benzaldehyde (P∩O) and o-[(diphenylphosphino)benzylidene]analine (P∩N).

J. Zubieta, J. Babich, F. Femia, 2001, Inorganica chimica acta.

Phase I dose-escalation study of 225Ac-J591 for progressive metastatic castration resistant prostate cancer (mCRPC).

H. Beltran, S. Vallabhajosula, N. Bander, 2018 .

Complexes of the fac-{Re(CO)3}+ core with tridentate ligands derived from arylpiperazines

J. Zubieta, Lihui Wei, S. Banerjee, 2004 .

Synthesis and biological evaluation of two novel DAT-binding technetium complexes containing a piperidine based analogue of cocaine.

A. Kozikowski, J. Babich, K. Johnson, 1999, Bioorganic & medicinal chemistry letters.

Synthesis and structural characterization of the neutral indium (III) thiolate species In{(SCH2CH2)3N}

A. Fischman, J. Zubieta, J. Babich, 1998 .

Bifunctional single amino acid chelates for labeling of biomolecules with the {Tc(CO)3}+ and {Re(CO)3}+ cores. Crystal and molecular structures of [ReBr(CO)3(H2NCH2 C5H4N)], [Re(CO)3{(C5H4 NCH2)2NH}]Br,

J. Zubieta, Lihui Wei, J. Valliant, 2002 .

Synthesis and characterization of oxorhenium-`3 + 1' mixed-thiolate complexes. Crystal and molecular structures of [ReO{η3-(SCH2CH2)2S}(C6H4X-4-CH2S)] (X = F, Cl, Br, OMe) and of the pendant thiolate compounds [ReO{η3-(SCH2CH2)2S}(η1-SCH2CH2SCH2CH2SH)] and [ReO{η3-(SCH2CH2)2S}{η1-SCH2CH(OH)CH(OH)CH2

J. Zubieta, J. Babich, K. Maresca, 1999 .

Dose Escalation Study of No-Carrier-Added 131I-Metaiodobenzylguanidine for Relapsed or Refractory Neuroblastoma: New Approaches to Neuroblastoma Therapy Consortium Trial

S. Groshen, A. Panigrahy, J. Maris, 2012, The Journal of Nuclear Medicine.

A kit method for the high level synthesis of [211At]MABG.

M. Zalutsky, J. Babich, G. Vaidyanathan, 2007, Bioorganic & medicinal chemistry.

A new strategy for preparing molecular imaging and therapy agents using fluorine-rich (fluorous) soluble supports.

J. Valliant, P. Schaffer, J. Babich, 2006, Journal of the American Chemical Society.

A new bifunctional amino acid chelator targeting the glucose transporter

J. Zubieta, S. Banerjee, J. Babich, 2006 .

Schiff base chemistry of the {ReO} core: structural characterization of the unusual '3 + 2' complex [ReO(eta-OC(6)H(4)-CH=NC(6)H(4)-2-S)(eta-OC(6)H(4))].

J. Zubieta, J. Babich, F. Femia, 2000, Inorganica chimica acta.

Structural characterizations of an Re(IV) complex [ReCl4(OPPh3)2] and of an imino species [ReOCl2(PPh3)(η2-OC6H4-2-CHNH)] prepared from the reaction of [ReOCl3(PPh3)2] with salicylaldoxime

J. Zubieta, J. Babich, F. Femia, 2000 .

Investigations of the {ReO}3+ core: A '2 + 2' complex from bidentate and potentially trident ligands: [ReO(η2-HOC6H4-2-CH2NC6H4S)(η2-SC5H4N)(PPh3)]

J. Zubieta, J. Babich, F. Femia, 2000 .

Synthesis and characterization of complexes of the {ReO} core with SNS and S donor ligands.

J. Zubieta, T. Shoup, J. Babich, 2000, Inorganica chimica acta.

Structural systematics of the {ReO}3+ core with ‘3+2’ ligand donor sets

J. Zubieta, J. Babich, F. Femia, 2000 .

Oxorhenium(V) complexes containing tridentate Schiff-base and monothiol coligands.

J. Zubieta, J. Babich, F. Femia, 2000, Inorganica chimica acta.

Cationic complexes of the ‘3+1’ oxorhenium–thiolate family

J. Zubieta, J. Babich, K. Maresca, 2000 .

Infection imaging with technetium-99m-labeled chemotactic peptide analogs.

A. Fischman, R. Rubin, J. Babich, 1994, Seminars in nuclear medicine.

99mTc-labeled chemotactic peptides: influence of coligand on distribution of molecular species and infection imaging properties. Synthesis and structural characterization of model complexes with the {Re(η2-HNNC5H4N)(η1-NNC5H4N)} core

A. Fischman, J. Zubieta, J. Babich, 2000 .

Synthesis, Cytotoxicity, and Insight into the Mode of Action of Re(CO)3 Thymidine Complexes

J. Zubieta, M. Bartholomä, B. Ploier, 2010, ChemMedChem.

Synthesis, characterization and crystal structures of mono-, di- and trinuclear rhenium(I) tricarbonyl complexes with 2,3,5,6-tetra(2-pyridyl)pyrazine.

J. Zubieta, J. Babich, F. Femia, 2001, Inorganica chimica acta.

Novel ether-containing ligands as potential 99mtechnetium(I) heart agents

J. Zubieta, J. Babich, K. Maresca, 2007 .

Developing the {M(CO)3}+ core for fluorescence applications: Rhenium tricarbonyl core complexes with benzimidazole, quinoline, and tryptophan derivatives.

J. Zubieta, Lihui Wei, W. Ouellette, 2006, Inorganic chemistry.

Rhenium tricarbonyl core complexes of thymidine and uridine derivatives.

J. Zubieta, Lihui Wei, W. Eckelman, 2005, Inorganic chemistry.

Exploring oxorhenium '3+1' mixed-ligand complexes carrying the S-benzyl-3-[(2-hydroxyphenyl)methylene]dithiocarbazate [ONS]/monothiol [S] donor set: synthesis and characterization.

J. Zubieta, J. Babich, F. Femia, 2000, Inorganica chimica acta.

Single amino acid chelates (SAAC): a strategy for the design of technetium and rhenium radiopharmaceuticals.

J. Zubieta, J. Valliant, M. Bartholomä, 2009, Chemical communications.

Unusual reactivity of the [Re(V)O]3+ core: syntheses and characterization of novel rhenium halide complexes with n-methyl-o-diaminobenzene.

J. Zubieta, Lihui Wei, J. Babich, 2004, Inorganic chemistry.

Rhenium(I) carbonyl complexes of 2,4,6-tris(2-pyridyl)-1,3,5-triazine (TPT). Rhenium(I)-promoted methoxylation of the triazine ring carbon atom in dinuclear rhenium complexes.

J. Zubieta, J. Babich, F. Femia, 2001, Inorganic chemistry.

Synthesis and characterization of oxorhenium(V)–‘3+1’ mixed thiolate [SNS]/[S] and [ONS]/[S] complexes. Crystal and molecular structures of [ReO(η3-SCH2C5H3NCH2S)(η1-C6H4Br-4-S)], [ReO(η3-SCH2C5H3NCH2O)(η1-C6H4X-4-S)] (X=Cl, OMe), [ReO(η3-SCH2C5H3NCH2O)(η1-C6H4OCH3-4-CH2S)] and [ReO(η3-SCH2C5H3NCH2S

J. Zubieta, J. Babich, F. Femia, 2000 .

A convenient solid-phase synthesis methodology for preparing peptide-derived molecular imaging agents Synthesis, characterization, and in vitro screening of Tc(I) chemotactic peptide conjugates

J. Zubieta, J. Valliant, N. McFarlane, 2005 .

Bifunctional chelates with mixed aromatic and aliphatic amine donors for labeling of biomolecules with the {Tc(CO)3}+ and {Re(CO)3}+ cores

J. Zubieta, Lihui Wei, J. Babich, 2005 .

Evaluation of phenylpiperazines as targeting agents for neuroblastoma.

A. Fischman, J. Babich, W. Graham, 1996, British Journal of Cancer.

Complexes of the {ReVOX2}+ (X = Cl, Br) core with single amino acid chelate derivatives

J. Zubieta, Lihui Wei, J. Babich, 2005 .

N,N-bis(2-mercaptoethyl)methylamine: a new coligand for Tc-99m labeling of hydrazinonicotinamide peptides.

A. Fischman, J. Zubieta, J. Valliant, 2005, Bioconjugate chemistry.

A robust strategy for the preparation of libraries of metallopeptides. A new paradigm for the discovery of targeted molecular imaging and therapy agents.

Nick Oakley, Jon Zubieta, John Joyal, 2008, Chemical communications.

Synthesis, cytotoxicity and cellular uptake studies of N3 functionalized Re(CO)3 thymidine complexes.

J. Zubieta, M. Bartholomä, J. Babich, 2011, Dalton transactions.

Radiopharmaceutical Therapy of Patients with Metastasized Melanoma with the Melanin-Binding Benzamide 131I-BA52

A. Enk, U. Haberkorn, F. Giesel, 2014, The Journal of Nuclear Medicine.

Synthesis of [11C]dapoxetine.HCl, a serotonin re-uptake inhibitor: biodistribution in rat and preliminary PET imaging in the monkey.

A. Fischman, J. Thrall, J. Babich, 1994, Nuclear medicine and biology.

Pharmacokinetics of [18F]fleroxacin in patients with acute exacerbations of chronic bronchitis and complicated urinary tract infection studied by positron emission tomography

N. Alpert, A. Fischman, J. Correia, 1996, Antimicrobial agents and chemotherapy.

Tissue pharmacokinetics of fleroxacin in humans as determined by positron emission tomography.

N. Alpert, A. Fischman, R. Rubin, 1994, International journal of antimicrobial agents.

Pharmacokinetics of [18F]fleroxacin in healthy human subjects studied by using positron emission tomography

N. Alpert, A. Fischman, J. Correia, 1993, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics of 18F-labeled fleroxacin in rabbits with Escherichia coli infections, studied with positron emission tomography

N. Alpert, A. Fischman, J. Correia, 1992, Antimicrobial Agents and Chemotherapy.

Gamma Irradiation and Targeted Radionuclides Enhance the Expression of the Noradrenaline Transporter Transgene Controlled by the Radio-Inducible p21WAF1/CIP1 Promoter

S. Pimlott, H. McCarthy, J. Babich, 2013, Radiation research.

Oxyaapa: A Picolinate-Based Ligand with Five Oxygen Donors that Strongly Chelates Lanthanides.

Justin J. Wilson, W. Zipfel, Robert A. DiStasio, 2020, Inorganic chemistry.

Targeting prostate cancer: Prostate‐specific membrane antigen based diagnosis and therapy

U. Haberkorn, J. Babich, W. Mier, 2019, Medicinal research reviews.

Synthesis and Evaluation of 11C-Labeled Triazolones as Probes for Imaging Fatty Acid Synthase Expression by Positron Emission Tomography

James M. Kelly, T. Jeitner, J. Babich, 2022, Molecules.

I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy

B. Hadaschik, U. Haberkorn, A. Afshar-Oromieh, 2014 .

First-in-Man Evaluation of 2 High-Affinity PSMA-Avid Small Molecules for Imaging Prostate Cancer

William C. Eckelman, James B. Stubbs, Stanley J. Goldsmith, 2013, The Journal of Nuclear Medicine.

123I-MIP-1072, a Small-Molecule Inhibitor of Prostate-Specific Membrane Antigen, Is Effective at Monitoring Tumor Response to Taxane Therapy

W. Eckelman, J. Marquis, J. Babich, 2011, The Journal of Nuclear Medicine.

Prostaglandin J2: a potential target for halting inflammation‐induced neurodegeneration

John Babich, J. Babich, M. Figueiredo-Pereira, 2016, Annals of the New York Academy of Sciences.

Prostaglandin D2/J2 signaling pathway in a rat model of neuroinflammation displaying progressive parkinsonian-like pathology: potential novel therapeutic targets

P. Serrano, S. Vallabhajosula, J. Babich, 2018, Journal of Neuroinflammation.

Prostaglandin D2/J2 signaling pathway in a rat model of neuroinflammation displaying progressive parkinsonian-like pathology: potential novel therapeutic targets

S. Vallabhajosula, J. Babich, A. Nikolopoulou, 2018, Journal of Neuroinflammation.

68Ga-PSMA 11 ligand PET imaging in patients with biochemical recurrence after radical prostatectomy – diagnostic performance and impact on therapeutic decision-making

W. Wadsak, S. Shariat, A. Haug, 2017, European Journal of Nuclear Medicine and Molecular Imaging.

PSMA Ligand PET/MRI for Primary Prostate Cancer: Staging Performance and Clinical Impact

T. Helbich, W. Wadsak, M. Mitterhauser, 2018, Clinical Cancer Research.

Comprehensive Quality Control of the ITG 68Ge/68Ga Generator and Synthesis of 68Ga-DOTATOC and 68Ga-PSMA-HBED-CC for Clinical Imaging

S. Vallabhajosula, J. Babich, M. Meckel, 2016, The Journal of Nuclear Medicine.

Preliminary evaluation of prostate‐targeted radiotherapy using 131I‐MIP‐1095 in combination with radiosensitising chemotherapeutic drugs

J. Babich, R. Mairs, C. Nixon, 2016, The Journal of pharmacy and pharmacology.

Isostructural fluorescent and radioactive probes for monitoring neural stem and progenitor cell transplants.

Leslie C. Reid, J. Zubieta, T. Farncombe, 2008, Nuclear medicine and biology.

An unexpected '4+2' [N(3)S]:[NS] rhenium(IV) complex formed upon cleavage of a Re(V) imido bond.

J. Zubieta, J. Babich, F. Femia, 2000, Inorganica chimica acta.

Quantitative Whole-Body Imaging of I-124-labeled Adeno-Associated Viral Vector Biodistribution in Nonhuman Primates.

P. Mozley, D. Ballon, R. Crystal, 2020, Human gene therapy.

Development of Novel Radiopharmaceuticals: Problems, Decisions and More Problems

U. Haberkorn, J. Babich, 2020 .

PMPA for Nephroprotection in PSMA-Targeted Radionuclide Therapy of Prostate Cancer

U. Haberkorn, F. Giesel, M. Eder, 2015, The Journal of Nuclear Medicine.

Intraindividual Comparison of 99mTc-Methylene Diphosphonate and Prostate-Specific Membrane Antigen Ligand 99mTc-MIP-1427 in Patients with Osseous Metastasized Prostate Cancer

T. Holland-Letz, U. Haberkorn, A. Afshar-Oromieh, 2018, The Journal of Nuclear Medicine.

Intraindividual Comparison of 99mTc-Methylene Diphosphonate and Prostate-Specific Membrane Antigen Ligand 99mTc-MIP-1427 in Patients with Osseous Metastasized Prostate Cancer

T. Holland-Letz, U. Haberkorn, A. Afshar-Oromieh, 2018, The Journal of Nuclear Medicine.

Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with 131I-MIP-1095

T. Holland-Letz, U. Haberkorn, A. Afshar-Oromieh, 2017, European Journal of Nuclear Medicine and Molecular Imaging.

99mTc-MIP-1404 Planar and SPECT scan: Imaging biomarker of androgen receptor (AR) signaling and prostate specific membrane antigen (PSMA) expression.

J. A. Epstein, S. Vallabhajosula, S. Tagawa, 2016 .

Radiation dosimetry and first therapy results with a 124I/131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy

B. Hadaschik, U. Haberkorn, A. Afshar-Oromieh, 2014, European Journal of Nuclear Medicine and Molecular Imaging.

Inhibiteurs de l'anhydrase carbonique ix

J. Babich, C. Barone, Genliang Lu, 2009 .

A Trifunctional Theranostic Ligand Targeting Fibroblast Activation Protein-α (FAPα)

James M. Kelly, T. Jeitner, J. Babich, 2021, Molecular Imaging and Biology.

The Rise of PSMA Ligands for Diagnosis and Therapy of Prostate Cancer

U. Haberkorn, A. Afshar-Oromieh, F. Giesel, 2016, The Journal of Nuclear Medicine.

Identification of Ligands and Translation to Clinical Applications

U. Haberkorn, K. Kopka, J. Babich, 2017, The Journal of Nuclear Medicine.

Longitudinal PET imaging demonstrates biphasic CAR T cell responses in survivors.

Benedict Law, M. Jin, J. Babich, 2016, JCI insight.

Thermal injury in rats alters glucose utilization by skin, wound, and small intestine, but not by skeletal muscle.

R. Tompkins, J. Babich, E. Bailey, 1996, Metabolism: clinical and experimental.

Technetium-99m-HMPAO retention and the role of glutathione: the debate continues.

J. Babich, 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Preclinical evaluation of peptide-based radiotracers for integrin αvβ6-positive pancreatic carcinoma

D. Jäger, U. Haberkorn, F. Marmé, 2019, Nuklearmedizin.

New Strategies in Prostate Cancer: Prostate-Specific Membrane Antigen (PSMA) Ligands for Diagnosis and Therapy

U. Haberkorn, M. Eder, M. Eisenhut, 2016, Clinical Cancer Research.

Metabolic Imaging With &bgr;-Methyl-p-[123I]-Iodophenyl-Pentadecanoic Acid Identifies Ischemic Memory After Demand Ischemia

V. Dilsizian, S. Bergmann, T. Bateman, 2005, Circulation.

Measurements of blood-brain barrier permeability in patients undergoing radiotherapy and chemotherapy for primary cerebral lymphoma.

S. Cherry, R. Ott, M. Brada, 1991, European journal of cancer.

Localization of radiolabeled chemotactic peptide at focal sites of Escherichia coli infection in rabbits: evidence for a receptor-specific mechanism.

R. Tompkins, J. Babich, W. Graham, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Kohlenstoffanhydrase-IX-Inhibitoren

J. Babich, C. Barone, Genliang Lu, 2009 .

Synthesis of 2-[18F]fluoro-2-deoxy-L-glucose and positron emission tomography studies in monkeys.

N. Alpert, A. Fischman, R. Tompkins, 1994, Nuclear Medicine and Biology.

Iodofiltic acid I 123 (BMIPP) fatty acid imaging improves initial diagnosis in emergency department patients with suspected acute coronary syndromes: a multicenter trial.

V. Dilsizian, Ernest V. Garcia, A. Iskandrian, 2010, Journal of the American College of Cardiology.

Effect of adrenergic receptor ligands on metaiodobenzylguanidine uptake and storage in neuroblastoma cells

A. Fischman, J. Babich, W. Graham, 1997, European Journal of Nuclear Medicine.

PET Tracers for Imaging Cardiac Function in Cardio-oncology

James M. Kelly, J. Babich, 2022, Current Cardiology Reports.

Muscle protein synthesis by positron-emission tomography with L-[methyl-11C]methionine in adult humans.

N. Alpert, A. Fischman, R. Tompkins, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Is nano too big?

U. Haberkorn, J. Babich, W. Mier, 2013, European Journal of Nuclear Medicine and Molecular Imaging.

Defining the origins of multiple emission/excitation in rhenium-bisthiazole complexes

T. Korter, J. Zubieta, M. Ruggiero, 2019, Inorganica Chimica Acta.

Single amino acid chelate complexes of the M(CO)3 (+) core for correlating fluorescence and radioimaging studies (M = (99m) Tc or Re).

J. Zubieta, J. Valliant, J. Babich, 2014, Journal of labelled compounds & radiopharmaceuticals.

Enhancement of fluid filtration across tumor vessels: implication for delivery of macromolecules.

A. Fischman, R. Jain, Y. Boucher, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Mapping of local renal blood flow with PET and H(2)(15)O.

N. Alpert, A. Fischman, C. Rabito, 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Development of a high performance zinc-62/copper-62 radionuclide generator for positron emission tomography

R. Ott, J. Babich, J. Zweit, 2004, European Journal of Nuclear Medicine.

Rapid detection of Parkinson's disease by SPECT with altropane: A selective ligand for dopamine transporters

N. Alpert, A. Fischman, E. P. Palmer, 1998, Synapse.

[18F]RPS-544: A PET tracer for imaging the chemokine receptor CXCR4.

James M. Kelly, M. Jin, J. Babich, 2018, Nuclear medicine and biology.

Inhibition of Poly(ADP-Ribose) Polymerase Enhances the Toxicity of 131I-Metaiodobenzylguanidine/Topotecan Combination Therapy to Cells and Xenografts That Express the Noradrenaline Transporter

S. Pimlott, M. Gaze, J. Babich, 2012, The Journal of Nuclear Medicine.

Synthesis of a 11C-labeled NK1 receptor ligand for PET studies.

Dennis M Godek, A. Fischman, M. Desai, 1995, Nuclear medicine and biology.

Diagnostic and therapeutic imaging for cancer: Therapeutic considerations and future directions

Francesco Verrecchia, Alessandro Testori, Ronald Gottlieb, 2011, Journal of surgical oncology.

Pharmacokinetics of [18F]Trovafloxacin in Healthy Human Subjects Studied with Positron Emission Tomography

N. Alpert, A. Fischman, J. Correia, 1998, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics of 18F-labeled trovafloxacin in normal and Escherichia coli-infected rats and rabbits studied with positron emission tomography.

N. Alpert, A. Fischman, J. Correia, 1997, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Rhenium tricarbonyl core complexes with ligands derived from arylpiperazines. The structures of [Re(CO)3{NC5H4CH2N(H)CH2CH2–Fphenpip}]Br, [Re(CO)3{(NC5H4CH2)2N(CH2)3–CH3OphenpipH}]Br2 and [Re(CO)3{(CH3N2C3H2CH2)(O2CCH2)N(CH2)3–CH3OphenpipH2}]BrCl

J. Zubieta, Lihui Wei, S. Banerjee, 2003 .

Phase 2 Study of 99mTc-Trofolastat SPECT/CT to Identify and Localize Prostate Cancer in Intermediate- and High-Risk Patients Undergoing Radical Prostatectomy and Extended Pelvic LN Dissection

John Babich, Thomas Strack, Steven Joniau, 2017, The Journal of Nuclear Medicine.

Advanced Fibroblast Activation Protein-Ligand Developments: FAP Imaging Agents: A Review of the Structural Requirements.

J. Babich, S. DiMagno, 2023, PET clinics.

Molecular Imaging of Prostate Cancer: Radiopharmaceuticals for Positron Emission Tomography (PET) and Single-Photon Emission Computed Tomography (SPECT)

S. Vallabhajosula, J. Babich, B. Polack, 2018 .

Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer.

Martin G Pomper, William C Eckelman, John W Babich, 2009, Cancer research.

A suitable time point for quantifying the radiochemical purity of 225Ac-labeled radiopharmaceuticals

James M. Kelly, Justin J. Wilson, J. Babich, 2021, EJNMMI Radiopharmacy and Chemistry.

A Consensus Time for Performing Quality Control of 225Ac-Labeled Radiopharmaceuticals

James M. Kelly, James M. Kelly, Alejandro Amor-Coarasa, 2020 .

Assessment of PSMA targeting ligands bearing novel chelates with application to theranostics: Stability and complexation kinetics of 68Ga3+, 111In3+, 177Lu3+ and 225Ac3.

James M. Kelly, Shankar Vallabhajosula, Alejandro Amor-Coarasa, 2017, Nuclear medicine and biology.

Synthesis and pre-clinical evaluation of a new class of high-affinity 18F-labeled PSMA ligands for detection of prostate cancer by PET imaging

James M. Kelly, J. Babich, A. Nikolopoulou, 2016, European Journal of Nuclear Medicine and Molecular Imaging.

Quantification of dopamine transporter density in monkeys by dynamic PET imaging of multiple injections of 11C‐CFT

N. Alpert, S. Weise, A. Fischman, 1996, Synapse.

The Physics of Radioisotope Imaging

R. J. Ott, Paul Marsden, John W. Babich, 1988 .

Improved synthesis of the bifunctional chelator p-SCN-Bn-HOPO.

Jason S. Lewis, Minhua Cao, C. M. Drain, 2019, Organic & biomolecular chemistry.

Isostructural Re and 99mTc complexes of biotin derivatives for fluorescence and radioimaging studies.

J. Zubieta, L. Doering, J. Valliant, 2006, Bioconjugate chemistry.

Phase I study of 225Ac-J591 for men with metastatic castration-resistant prostate cancer (mCRPC).

S. Vallabhajosula, N. Bander, C. Sternberg, 2021 .

99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen: Pharmacokinetics and Biodistribution Studies in Healthy Subjects and Patients with Metastatic Prostate Cancer

S. Vallabhajosula, J. Osborne, S. Tagawa, 2014, The Journal of Nuclear Medicine.

Direct reductive alkylation of amino acids: Synthesis of bifunctional chelates for nuclear imaging

J. Zubieta, S. Banerjee, J. Babich, 2004 .

[11C,127I] Altropane: A highly selective ligand for PET imaging of dopamine transporter sites

N. Alpert, A. Fischman, J. Babich, 2001, Synapse.

Positron emission tomographic analysis of central 5-hydroxytryptamine2 receptor occupancy in healthy volunteers treated with the novel antipsychotic agent, ziprasidone.

N. Alpert, S. Rauch, A. Fischman, 1996, The Journal of pharmacology and experimental therapeutics.

Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain

A. Fischman, E. Stopa, J. Babich, 1998, Synapse.

Altropane, a SPECT or PET imaging probe for dopamine neurons: I. dopamine transporter binding in primate brain

A. Fischman, J. Babich, B. Madras, 1998, Synapse.

SPECT imaging of dopamine transporter sites in normal and MPTP-Treated rhesus monkeys.

A. Fischman, R. Hanson, J. Babich, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Synthesis of fluorine-18-labeled biotin derivatives: biodistribution and infection localization.

A. Fischman, H. Strauss, T. Shoup, 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Novel monoamine transporter ligands reduce cocaine-induced enhancement of brain stimulation reward

Kenneth M. Johnson, J. Stellar, S. Choi, 2001, Pharmacology Biochemistry and Behavior.

Synthesis and screening of a library of Re/Tc-based amyloid probes derived from beta-breaker peptides.

Leslie C. Reid, H. Kung, J. Zubieta, 2008, Bioconjugate chemistry.

The biodistribution and pharmacokinetics of meta-iodobenzylguanidine in childhood neuroblastoma

R. Ott, J. Babich, I. Gordon, 2007, European Journal of Nuclear Medicine.

66Ga: A Novelty or a Valuable Preclinical Screening Tool for the Design of Targeted Radiopharmaceuticals?

James M. Kelly, J. Babich, A. Nikolopoulou, 2018, Molecules.

Extension of the single amino acid chelate concept (SAAC) to bifunctional biotin analogues for complexation of the M(CO)3(+1) Core (M = Tc and Re): syntheses, characterization, biotinidase stability, and avidin binding.

J. Zubieta, J. Valliant, W. Eckelman, 2006, Bioconjugate chemistry.

A gamma camera for medical applications, using a multiwire proportional counter.

L. Latson, J. Babich, M. W. Bungo, 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Synthesis and Characterization of Organohydrazino Complexes of Technetium, Rhenium, and Molybdenum with the {M(eta(1)-H(x)()NNR)(eta(2)-H(y)()NNR)} Core and Their Relationship to Radiolabeled Organohydrazine-Derivatized Chemotactic Peptides with Diagnostic Applications.

Alun G. Jones, A. Fischman, J. Zubieta, 1998, Inorganic chemistry.

3D-printed automation for optimized PET radiochemistry

James M. Kelly, Alejandro Amor-Coarasa, John W Babich, 2019, Science Advances.

Tissue blood flow estimation with copper(II)-pyruvaldehyde bis (N-4-methylthiosemicarbazone) and PET.

S. Cherry, R. Ott, J. Babich, 1994, Journal of nuclear biology and medicine.

BLOOD-BRAIN BARRIER (BBB) STUDIES OF PATIENTS WITH PRIMARY BRAIN NEOPLASMS USING POSITRON EMISSION TOMOGRAPHY (PET)

V. R. McCready, S. Webb, P. Marsden, 1988 .

Pharmacokinetics of 18F-labeled trovafloxacin in normal and Escherichia coli-infected rats and rabbits studied with positron emission tomography.

N. Alpert, A. Fischman, R. Rubin, 1997, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Evaluation of copper(II)-pyruvaldehyde bis (N-4-methylthiosemicarbazone) for tissue blood flow measurement usina a trapped tracer model

S. Cherry, R. Ott, J. Babich, 2004, European Journal of Nuclear Medicine.

2200 A PHASE 1 PILOT STUDY OF 99MTC-MIP-1404 SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT)/CT IMAGING IN MEN WITH PROSTATE CANCER UNDERGOING RADICAL PROSTATECTOMY

S. Vallabhajosula, J. Osborne, B. Robinson, 2013 .

Pharmacokinetics of fleroxacin as studied by positron emission tomography and [18F]fleroxacin.

N. Alpert, J. Correia, R. Rubin, 1993, The American journal of medicine.

Therapeutic implications of the uptake of radiolabelled mIBG for the treatment of neuroblastoma.

A. Barrett, T. Wheldon, J. Babich, 1991, Progress in clinical and biological research.

Preclinical evaluation of no-carrier-added [131I]meta-iodobenzyl guanidine, for the treatment of tumours transfected with the noradrenaline transporter gene

M. Zalutsky, J. Babich, M. Boyd, 2004 .

A phase I/II dose-escalation study of fractionated and multiple dose 225Ac-J591 for progressive metastatic castration-resistant prostate cancer (mCRPC).

S. Vallabhajosula, N. Bander, C. Sternberg, 2021 .

In Vivo Imaging of Fibroblast Activity Using a 68Ga-Labeled Fibroblast Activation Protein Alpha (FAP-α) Inhibitor

S. Rodeo, J. Babich, Xiang-Hua Deng, 2021, The Journal of bone and joint surgery. American volume.

Comparison of radiohaloanalogues of meta-iodobenzylguanidine (MIBG) for a combined gene- and targeted radiotherapy approach to bladder carcinoma.

S. Pimlott, M. Zalutsky, J. Babich, 2005, Medicinal chemistry (Shariqah (United Arab Emirates)).

Population-based input function for TSPO quantification and kinetic modeling with [11C]-DPA-713

S. Nehmeh, P. Mozley, M. Akerele, 2021, EJNMMI Physics.

Muscle protein synthesis by positron-emission tomography with L-[ methyl-11 C ] methionine in adult humans ( skeletal muscle y fractional synthesis rate )

N. Alpert, A. Fischman, R. Tompkins, 1998 .

Measurement of muscle protein synthesis by positron emission tomography with L-[ methyl-1 C ] methionine ( hind limb / arteriovenous difference / stable isotope / paraspinal muscle / dog )

N. Alpert, A. Fischman, J. Babich, 2005 .

Glu-Ureido–Based Inhibitors of Prostate-Specific Membrane Antigen: Lessons Learned During the Development of a Novel Class of Low-Molecular-Weight Theranostic Radiotracers

U. Haberkorn, K. Kopka, J. Babich, 2017, The Journal of Nuclear Medicine.

New Strategies in Prostate Cancer: Prostate-Specific Membrane Antigen (PSMA) Ligands for Diagnosis and Therapy

U. Haberkorn, M. Eder, M. Eisenhut, 2016, Clinical Cancer Research.

Tc-99m labeled small-molecule inhibitors of prostate-specific membrane antigen (PSMA): New molecular imaging probes to detect metastatic prostate adenocarcinoma (PC).

S. Vallabhajosula, J. Osborne, S. Tagawa, 2012, Journal of Clinical Oncology.

Intra-individual comparison of Tc-99m-MDP bone scan and the PSMA-ligand Tc-99m-MIP-1427 in patients with osseous metastasized prostate cancer

T. Holland-Letz, U. Haberkorn, A. Afshar-Oromieh, 2018 .

Novel polar single amino acid chelates for technetium-99m tricarbonyl-based radiopharmaceuticals with enhanced renal clearance: application to octreotide.

W. Eckelman, J. Marquis, J. Babich, 2010, Bioconjugate chemistry.

Otto: a 4.04 GBq (109 mCi) 68Ge/68Ga generator, first of its kind - extended quality control and performance evaluation in the clinical production of [68Ga]Ga-PSMA-11

J. Babich, A. Nikolopoulou, Nicole N. Waterhouse, 2020, EJNMMI Radiopharmacy and Chemistry.

A phase II study of 99mTc-trofolastat (MIP-1404) SPECT/CT to identify and localize prostate cancer in high-risk patients undergoing radical prostatectomy (RP) and extended pelvic lymph node dissection (EPLND) compared to histopathology: An interim analysis.

W. Ellis, E. Klein, N. Stambler, 2014 .

Positron-emitting PSMA inhibitors for molecular imaging of prostate cancer

M. Pomper, A. Kozikowski, J. Babich, 2008 .

Rapid noninvasive detection of experimental atherosclerotic lesions with novel 99mTc-labeled diadenosine tetraphosphates.

A. Fischman, E. Rapaport, P. Zamecnik, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Small molecule inhibitors of prostate specific membrane antigen (PSMA) for SPECT: Summary of phase I studies in patients with prostate cancer (PCa)

S. Vallabhajosula, J. Osborne, S. Goldsmith, 2012 .

PSMA targeted SPECT imaging biomarker to detect local and metastatic prostate cancer (PCa): Phase I studies with 99mTc-MIP-1404

S. Vallabhajosula, J. Osborne, S. Tagawa, 2013 .

Targeting metastatic prostate cancer [PCa] in patients with 123I-MIP1072 & 123I-MIP1095

R. Coleman, S. Vallabhajosula, N. Petry, 2009 .

Role of Radiolabelled Small Molecules Binding to PSMA in Diagnosis and Therapy of Prostate Cancer

U. Haberkorn, M. Eder, M. Eisenhut, 2017 .

Metastatic Prostate Cancer Pharmacokinetics and Biodistribution Studies in Healthy Subjects and Patients with Tc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen : 99

S. Vallabhajosula, J. Osborne, S. Tagawa, 2014 .

Continuation of comprehensive quality control of the itG 68Ge/68Ga generator and production of 68Ga-DOTATOC and 68Ga-PSMA-HBED-CC for clinical research studies.

James M. Kelly, S. Vallabhajosula, J. Babich, 2017, Nuclear medicine and biology.

Inhibition of Fatty Acid Synthase Sensitizes Prostate Cancer Cells to Radiotherapy

U. Haberkorn, J. Babich, R. Mairs, 2015, Radiation research.

Differential in radiosensitizing potency of enantiomers of the fatty acid synthase inhibitor C75

J. Babich, R. Mairs, C. Rae, 2016, Chirality.

An evaluation of99mTc-HMPAO uptake in cerebral gliomas —a comparison with X-ray CT

R. Ott, M. Flower, J. Babich, 2004, European Journal of Nuclear Medicine.

[Re(III)Cl(3)] core complexes with bifunctional single amino acid chelates.

J. Zubieta, Lihui Wei, J. Valliant, 2002, Inorganic Chemistry.

Comprehensive radiolabeling, stability, and tissue distribution studies of technetium-99m single amino acid chelates (SAAC).

J. Zubieta, J. Valliant, S. Banerjee, 2009, Bioconjugate chemistry.

Synthesis and Evaluation of a Series of 99mTc(CO)3+ Lisinopril Complexes for In Vivo Imaging of Angiotensin-Converting Enzyme Expression

V. Dilsizian, W. Eckelman, J. Babich, 2008, Journal of Nuclear Medicine.

Comprehensive Quality Control of the ITG 68Ge/68Ga Generator and Synthesis of 68Ga-DOTATOC and 68Ga-PSMA-HBED-CC for Clinical Imaging

S. Vallabhajosula, J. Babich, M. Meckel, 2016, The Journal of Nuclear Medicine.